Novartis corporate press kit
Novartis is a world leader in the research, development, manufacturing and marketing of products to protect and improve health and well-being. Our goal is to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.
Français
|
Vue d'ensemble |
|
Novartis en un coup d'oeil |
|
Pharmaceuticals |
|
Vaccins et Diagnostic |
|
Sandoz |
|
Sandoz en un coup d'oeil |
|
Consumer Health |
|
OTC |
|
Animal Health |
|
CIBA Vision |
|
Recherche et Développement |
|
Corporate Research |
|
Collaborateurs |
||
|
Management |
||
|
|
||
|
Biographies |
Photos |
|
|
Daniel Vasella |
B/W |
Color |
|
Raymund Breu |
B/W |
Color |
|
Juergen Brokatzky-Geiger |
B/W |
Color |
|
David Epstein |
B/W |
Color |
|
Mark C. Fishman |
B/W |
Color |
|
Jeff George |
B/W |
Color |
|
George Gunn |
B/W |
Color |
|
Joseph Jimenez |
B/W |
Color |
|
Andrin Oswald |
B/W |
Color |
|
Joerg Reinhardt |
B/W |
Color |
|
Andreas Rummelt |
B/W |
Color |
|
Thomas Wellauer |
B/W |
Color |
|
Thomas Werlen |
B/W |
Color |
|
Citoyenneté d'entreprise |
|
Press Kit |
The information in the press kit on these pages was factually accurate on the date of publication, January 28, 2009. This press kit remains on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Get Novartis Media Releases through RSS
Stay Connected
Receive updates on company news and announcements.
Research
Novartis is working to build the most promising pipeline in the industry to treat and help people around the world.